<DOC>
	<DOC>NCT00528099</DOC>
	<brief_summary>To assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of ascending, single subcutaneous or intravenous doses of IMA-026 in healthy Japanese male subjects</brief_summary>
	<brief_title>Study Evaluating IMA-026 in Healthy Japanese Males</brief_title>
	<detailed_description />
	<criteria>Men ages 20 to 40 years, inclusive, at screening Body mass index (BMI) in the range of 17.6 to 26.4 kg/m2 and body weight &gt; 45 kg Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vitals signs, and 12 lead ECG.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>